

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 6.41135341 |
| 2 | cytidine catabolic process (GO:0006216) | 6.41135341 |
| 3 | cytidine deamination (GO:0009972) | 6.41135341 |
| 4 | DNA deamination (GO:0045006) | 5.96726667 |
| 5 | NIK/NF-kappaB signaling (GO:0038061) | 5.64852250 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.63827501 |
| 7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.61881370 |
| 8 | sequestering of actin monomers (GO:0042989) | 4.95845869 |
| 9 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.92108596 |
| 10 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.72313919 |
| 11 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.69853226 |
| 12 | actin nucleation (GO:0045010) | 4.33885288 |
| 13 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.25390119 |
| 14 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.25390119 |
| 15 | positive T cell selection (GO:0043368) | 4.00287978 |
| 16 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.98669078 |
| 17 | programmed necrotic cell death (GO:0097300) | 3.96121655 |
| 18 | positive regulation of tolerance induction (GO:0002645) | 3.95763656 |
| 19 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.91891092 |
| 20 | GPI anchor biosynthetic process (GO:0006506) | 3.78192574 |
| 21 | GPI anchor metabolic process (GO:0006505) | 3.71046454 |
| 22 | cellular ketone body metabolic process (GO:0046950) | 3.69910944 |
| 23 | regulation of T cell tolerance induction (GO:0002664) | 3.61112951 |
| 24 | electron transport chain (GO:0022900) | 3.60314265 |
| 25 | regulation of RIG-I signaling pathway (GO:0039535) | 3.60155068 |
| 26 | respiratory electron transport chain (GO:0022904) | 3.55266409 |
| 27 | necrotic cell death (GO:0070265) | 3.53381087 |
| 28 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.53125217 |
| 29 | negative regulation of T cell apoptotic process (GO:0070233) | 3.52725359 |
| 30 | mannosylation (GO:0097502) | 3.43112101 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.43055845 |
| 32 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.40702496 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.40169486 |
| 34 | tryptophan catabolic process (GO:0006569) | 3.37163427 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 3.37163427 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 3.37163427 |
| 37 | ketone body metabolic process (GO:1902224) | 3.32216701 |
| 38 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.31122737 |
| 39 | regulation of tolerance induction (GO:0002643) | 3.29031725 |
| 40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.24678920 |
| 41 | negative regulation of viral genome replication (GO:0045071) | 3.23260938 |
| 42 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.21966490 |
| 43 | cytolysis (GO:0019835) | 3.20915417 |
| 44 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.16304909 |
| 45 | kynurenine metabolic process (GO:0070189) | 3.15429575 |
| 46 | ATP synthesis coupled proton transport (GO:0015986) | 3.13480851 |
| 47 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.13480851 |
| 48 | regulation of ruffle assembly (GO:1900027) | 3.12091846 |
| 49 | eosinophil chemotaxis (GO:0048245) | 3.11707637 |
| 50 | regulation of cell killing (GO:0031341) | 3.11561359 |
| 51 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.10552068 |
| 52 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.10469785 |
| 53 | cornea development in camera-type eye (GO:0061303) | 3.09401304 |
| 54 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.98905977 |
| 55 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.98905977 |
| 56 | regulation of regulatory T cell differentiation (GO:0045589) | 2.95762609 |
| 57 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.95056211 |
| 58 | positive regulation of cell killing (GO:0031343) | 2.89554370 |
| 59 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.88634918 |
| 60 | behavioral response to ethanol (GO:0048149) | 2.87602341 |
| 61 | regulation of protein polyubiquitination (GO:1902914) | 2.86131899 |
| 62 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.84916584 |
| 63 | platelet dense granule organization (GO:0060155) | 2.84906396 |
| 64 | positive regulation of prostaglandin secretion (GO:0032308) | 2.84142310 |
| 65 | eosinophil migration (GO:0072677) | 2.83822049 |
| 66 | sulfation (GO:0051923) | 2.81396211 |
| 67 | negative T cell selection (GO:0043383) | 2.80561896 |
| 68 | amine catabolic process (GO:0009310) | 2.80313978 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 2.80313978 |
| 70 | cytochrome complex assembly (GO:0017004) | 2.78387377 |
| 71 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.78287815 |
| 72 | C-terminal protein amino acid modification (GO:0018410) | 2.77599734 |
| 73 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.77307725 |
| 74 | xenobiotic catabolic process (GO:0042178) | 2.76257845 |
| 75 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.75370716 |
| 76 | necroptotic process (GO:0070266) | 2.74239471 |
| 77 | alkaloid metabolic process (GO:0009820) | 2.69228990 |
| 78 | natural killer cell activation (GO:0030101) | 2.68584892 |
| 79 | tryptophan metabolic process (GO:0006568) | 2.65300724 |
| 80 | negative regulation of cell killing (GO:0031342) | 2.65037761 |
| 81 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.65037761 |
| 82 | response to interferon-beta (GO:0035456) | 2.63367629 |
| 83 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.63177078 |
| 84 | regulation of interleukin-8 secretion (GO:2000482) | 2.61870698 |
| 85 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.61606173 |
| 86 | negative regulation of oxidoreductase activity (GO:0051354) | 2.60515220 |
| 87 | glycolipid biosynthetic process (GO:0009247) | 2.60385152 |
| 88 | positive regulation of B cell differentiation (GO:0045579) | 2.59837820 |
| 89 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.59713542 |
| 90 | positive regulation of fatty acid transport (GO:2000193) | 2.59660445 |
| 91 | C-terminal protein lipidation (GO:0006501) | 2.58264280 |
| 92 | indolalkylamine metabolic process (GO:0006586) | 2.56331287 |
| 93 | positive regulation of icosanoid secretion (GO:0032305) | 2.56213654 |
| 94 | positive regulation of interleukin-4 production (GO:0032753) | 2.55615353 |
| 95 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.55038457 |
| 96 | hydrogen ion transmembrane transport (GO:1902600) | 2.52760745 |
| 97 | regulation of T cell apoptotic process (GO:0070232) | 2.51127133 |
| 98 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.48944201 |
| 99 | regulation of activation of Janus kinase activity (GO:0010533) | 2.47339147 |
| 100 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.46685741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.16245608 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.93602967 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.76314627 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.51276596 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.42538504 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.49725229 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.46491156 |
| 8 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14589469 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.05336916 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.04541065 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.03492640 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98555420 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.97576185 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.94870993 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89636078 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.84965573 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 1.78870193 |
| 18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.72876940 |
| 19 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.68551358 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67664386 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66259880 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.62943846 |
| 23 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.60258587 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59879845 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.52450220 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.52282585 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 1.51380783 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.50551274 |
| 29 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.50097405 |
| 30 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.50097405 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.44976514 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43997642 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42772802 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42759355 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.42546887 |
| 36 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.40401619 |
| 37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.32901071 |
| 38 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.32395503 |
| 39 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.31859517 |
| 40 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31859517 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29553158 |
| 42 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28767830 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28355026 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27933963 |
| 45 | AR_20517297_ChIP-Seq_VCAP_Human | 1.24116363 |
| 46 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.23067139 |
| 47 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.22166602 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19167153 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.18048937 |
| 50 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17923527 |
| 51 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.17845744 |
| 52 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.17049973 |
| 53 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16853828 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.16768244 |
| 55 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16581425 |
| 56 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16581425 |
| 57 | RXR_22108803_ChIP-Seq_LS180_Human | 1.15762837 |
| 58 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.15319541 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14677208 |
| 60 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14338399 |
| 61 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14338399 |
| 62 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13562302 |
| 63 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.12332560 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11983592 |
| 65 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.11381286 |
| 66 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.11183976 |
| 67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08794479 |
| 68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08337770 |
| 69 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08138863 |
| 70 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.06147433 |
| 71 | MYB_26560356_Chip-Seq_TH1_Human | 1.05625060 |
| 72 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.05393828 |
| 73 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04509142 |
| 74 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.03682107 |
| 75 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.03643596 |
| 76 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03446843 |
| 77 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03412085 |
| 78 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03219937 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03146229 |
| 80 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02213599 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01851832 |
| 82 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00973593 |
| 83 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.00944692 |
| 84 | ERA_21632823_ChIP-Seq_H3396_Human | 1.00291363 |
| 85 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.00174068 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99363863 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99214982 |
| 88 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.98737844 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96694141 |
| 90 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95771298 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93463687 |
| 92 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.93330644 |
| 93 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.93029159 |
| 94 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.91756325 |
| 95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91382948 |
| 96 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90870090 |
| 97 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.90723710 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90515015 |
| 99 | GATA3_26560356_Chip-Seq_TH1_Human | 0.89584161 |
| 100 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88940030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.66382961 |
| 2 | MP0009785_altered_susceptibility_to | 3.07065619 |
| 3 | MP0008877_abnormal_DNA_methylation | 2.67571402 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.67222963 |
| 5 | MP0000372_irregular_coat_pigmentation | 2.25832305 |
| 6 | MP0005387_immune_system_phenotype | 2.24938625 |
| 7 | MP0001790_abnormal_immune_system | 2.24938625 |
| 8 | MP0003011_delayed_dark_adaptation | 2.15113390 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.10678107 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.08363774 |
| 11 | MP0001800_abnormal_humoral_immune | 2.07166206 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.05217670 |
| 13 | MP0002909_abnormal_adrenal_gland | 2.02155624 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 1.98749546 |
| 15 | MP0005025_abnormal_response_to | 1.98595013 |
| 16 | MP0001905_abnormal_dopamine_level | 1.92127532 |
| 17 | MP0009764_decreased_sensitivity_to | 1.91840319 |
| 18 | MP0002723_abnormal_immune_serum | 1.90123889 |
| 19 | MP0003787_abnormal_imprinting | 1.85822991 |
| 20 | MP0002420_abnormal_adaptive_immunity | 1.84501376 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.83049103 |
| 22 | MP0001819_abnormal_immune_cell | 1.78522859 |
| 23 | MP0006082_CNS_inflammation | 1.72042337 |
| 24 | MP0004142_abnormal_muscle_tone | 1.67878651 |
| 25 | MP0002277_abnormal_respiratory_mucosa | 1.64691607 |
| 26 | MP0002006_tumorigenesis | 1.60545631 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.59193464 |
| 28 | MP0005551_abnormal_eye_electrophysiolog | 1.58823900 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.55366362 |
| 30 | MP0000685_abnormal_immune_system | 1.53239970 |
| 31 | MP0006072_abnormal_retinal_apoptosis | 1.52382477 |
| 32 | MP0000716_abnormal_immune_system | 1.50628170 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.50372723 |
| 34 | MP0002933_joint_inflammation | 1.48460345 |
| 35 | MP0006035_abnormal_mitochondrial_morpho | 1.46094275 |
| 36 | MP0005253_abnormal_eye_physiology | 1.44332593 |
| 37 | MP0002009_preneoplasia | 1.40341919 |
| 38 | MP0003195_calcinosis | 1.38708960 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.37071004 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.36288202 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.35366770 |
| 42 | MP0008872_abnormal_physiological_respon | 1.35232252 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.35094043 |
| 44 | MP0003878_abnormal_ear_physiology | 1.33948053 |
| 45 | MP0005377_hearing/vestibular/ear_phenot | 1.33948053 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.32692615 |
| 47 | MP0002398_abnormal_bone_marrow | 1.30262982 |
| 48 | MP0005310_abnormal_salivary_gland | 1.29104641 |
| 49 | MP0003646_muscle_fatigue | 1.28295075 |
| 50 | MP0001919_abnormal_reproductive_system | 1.26289436 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.26013517 |
| 52 | MP0003448_altered_tumor_morphology | 1.23568839 |
| 53 | MP0001873_stomach_inflammation | 1.23104153 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.20605086 |
| 55 | MP0002419_abnormal_innate_immunity | 1.16549052 |
| 56 | MP0004019_abnormal_vitamin_homeostasis | 1.16256598 |
| 57 | MP0004510_myositis | 1.12937997 |
| 58 | MP0003137_abnormal_impulse_conducting | 1.11084658 |
| 59 | MP0002722_abnormal_immune_system | 1.09062710 |
| 60 | MP0002405_respiratory_system_inflammati | 1.08924216 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.07193170 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04657804 |
| 63 | MP0002429_abnormal_blood_cell | 1.03985841 |
| 64 | MP0002102_abnormal_ear_morphology | 1.02916744 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.02530064 |
| 66 | MP0002733_abnormal_thermal_nociception | 1.02383168 |
| 67 | MP0002095_abnormal_skin_pigmentation | 1.02163663 |
| 68 | MP0001853_heart_inflammation | 1.02003799 |
| 69 | MP0005423_abnormal_somatic_nervous | 1.01510038 |
| 70 | MP0009745_abnormal_behavioral_response | 1.00556958 |
| 71 | MP0002272_abnormal_nervous_system | 0.99962566 |
| 72 | MP0000703_abnormal_thymus_morphology | 0.99834045 |
| 73 | MP0001970_abnormal_pain_threshold | 0.99637667 |
| 74 | MP0009046_muscle_twitch | 0.98384285 |
| 75 | MP0008469_abnormal_protein_level | 0.97698478 |
| 76 | MP0004742_abnormal_vestibular_system | 0.96956544 |
| 77 | MP0002736_abnormal_nociception_after | 0.96229341 |
| 78 | MP0002693_abnormal_pancreas_physiology | 0.95849185 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.95646483 |
| 80 | MP0003724_increased_susceptibility_to | 0.93549167 |
| 81 | MP0000639_abnormal_adrenal_gland | 0.89477180 |
| 82 | MP0000230_abnormal_systemic_arterial | 0.89016240 |
| 83 | MP0003866_abnormal_defecation | 0.88241961 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.88211877 |
| 85 | MP0005166_decreased_susceptibility_to | 0.87963108 |
| 86 | MP0002064_seizures | 0.87798754 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 0.85809437 |
| 88 | MP0000383_abnormal_hair_follicle | 0.85257271 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 0.82830732 |
| 90 | MP0001502_abnormal_circadian_rhythm | 0.79024996 |
| 91 | MP0003075_altered_response_to | 0.78536375 |
| 92 | MP0001963_abnormal_hearing_physiology | 0.77050633 |
| 93 | MP0005389_reproductive_system_phenotype | 0.75114783 |
| 94 | MP0002638_abnormal_pupillary_reflex | 0.74338434 |
| 95 | MP0001485_abnormal_pinna_reflex | 0.74025012 |
| 96 | MP0002837_dystrophic_cardiac_calcinosis | 0.74010009 |
| 97 | MP0005084_abnormal_gallbladder_morpholo | 0.73985225 |
| 98 | MP0001661_extended_life_span | 0.73711782 |
| 99 | MP0009763_increased_sensitivity_to | 0.73074975 |
| 100 | MP0001764_abnormal_homeostasis | 0.72866633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatocellular necrosis (HP:0001404) | 3.83748187 |
| 2 | Mitochondrial inheritance (HP:0001427) | 3.80314943 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 3.79199007 |
| 4 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.54367332 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.45871387 |
| 6 | Amyotrophic lateral sclerosis (HP:0007354) | 3.36870076 |
| 7 | IgG deficiency (HP:0004315) | 3.32569252 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.28763169 |
| 9 | Hepatic necrosis (HP:0002605) | 3.28335233 |
| 10 | Increased CSF lactate (HP:0002490) | 3.21892371 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.06753817 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.04939121 |
| 13 | Thyroiditis (HP:0100646) | 2.99336867 |
| 14 | Increased IgM level (HP:0003496) | 2.98041220 |
| 15 | Hypoproteinemia (HP:0003075) | 2.94032898 |
| 16 | Combined immunodeficiency (HP:0005387) | 2.91416075 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.89953166 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.89953166 |
| 19 | Decreased central vision (HP:0007663) | 2.88546257 |
| 20 | Increased hepatocellular lipid droplets (HP:0006565) | 2.88039607 |
| 21 | Increased intramyocellular lipid droplets (HP:0012240) | 2.78977274 |
| 22 | Generalized aminoaciduria (HP:0002909) | 2.76358325 |
| 23 | Progressive macrocephaly (HP:0004481) | 2.75799728 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 2.75411636 |
| 25 | Global brain atrophy (HP:0002283) | 2.75070121 |
| 26 | Recurrent bronchitis (HP:0002837) | 2.72347228 |
| 27 | Congenital stationary night blindness (HP:0007642) | 2.71585873 |
| 28 | Attenuation of retinal blood vessels (HP:0007843) | 2.70619458 |
| 29 | Lipid accumulation in hepatocytes (HP:0006561) | 2.67833942 |
| 30 | Pancreatic cysts (HP:0001737) | 2.67386788 |
| 31 | True hermaphroditism (HP:0010459) | 2.64152374 |
| 32 | Acute encephalopathy (HP:0006846) | 2.63941295 |
| 33 | Molar tooth sign on MRI (HP:0002419) | 2.54421901 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 2.54421901 |
| 35 | Abnormality of eosinophils (HP:0001879) | 2.48413695 |
| 36 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.48381192 |
| 37 | Aplastic anemia (HP:0001915) | 2.45290562 |
| 38 | T lymphocytopenia (HP:0005403) | 2.45155297 |
| 39 | Renal Fanconi syndrome (HP:0001994) | 2.45083946 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.38349235 |
| 41 | Methylmalonic aciduria (HP:0012120) | 2.37969944 |
| 42 | Parakeratosis (HP:0001036) | 2.36580870 |
| 43 | Methylmalonic acidemia (HP:0002912) | 2.34363358 |
| 44 | Abnormality of the prostate (HP:0008775) | 2.34093514 |
| 45 | Encephalitis (HP:0002383) | 2.30712954 |
| 46 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.30555917 |
| 47 | Spastic paraparesis (HP:0002313) | 2.29929101 |
| 48 | Severe visual impairment (HP:0001141) | 2.24456287 |
| 49 | Abnormality of T cell number (HP:0011839) | 2.24118552 |
| 50 | Hyperglycinemia (HP:0002154) | 2.20573010 |
| 51 | Furrowed tongue (HP:0000221) | 2.15855426 |
| 52 | Focal motor seizures (HP:0011153) | 2.15211592 |
| 53 | Prostate neoplasm (HP:0100787) | 2.14738699 |
| 54 | Leukocytosis (HP:0001974) | 2.12278490 |
| 55 | Panhypogammaglobulinemia (HP:0003139) | 2.09075080 |
| 56 | J-shaped sella turcica (HP:0002680) | 2.08860448 |
| 57 | Optic disc pallor (HP:0000543) | 2.08453178 |
| 58 | Neuroendocrine neoplasm (HP:0100634) | 2.05921978 |
| 59 | Exertional dyspnea (HP:0002875) | 2.05441870 |
| 60 | Cerebral edema (HP:0002181) | 2.05396791 |
| 61 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.02450761 |
| 62 | Facial diplegia (HP:0001349) | 2.01867279 |
| 63 | Hematochezia (HP:0002573) | 2.01214783 |
| 64 | 3-Methylglutaconic aciduria (HP:0003535) | 2.00723212 |
| 65 | Hemiplegia (HP:0002301) | 2.00057702 |
| 66 | Abnormality of T cells (HP:0002843) | 2.00046877 |
| 67 | Lymphopenia (HP:0001888) | 1.99562431 |
| 68 | Abnormality of the renal cortex (HP:0011035) | 1.98820782 |
| 69 | Ketosis (HP:0001946) | 1.97601956 |
| 70 | Progressive cerebellar ataxia (HP:0002073) | 1.96628410 |
| 71 | Congenital, generalized hypertrichosis (HP:0004540) | 1.95231921 |
| 72 | Abnormal drinking behavior (HP:0030082) | 1.95031491 |
| 73 | Polydipsia (HP:0001959) | 1.95031491 |
| 74 | Large for gestational age (HP:0001520) | 1.93333382 |
| 75 | Abnormal number of erythroid precursors (HP:0012131) | 1.93181352 |
| 76 | Nephronophthisis (HP:0000090) | 1.91576590 |
| 77 | Meningitis (HP:0001287) | 1.90402555 |
| 78 | Chronic sinusitis (HP:0011109) | 1.89232432 |
| 79 | Leukodystrophy (HP:0002415) | 1.88863005 |
| 80 | Myositis (HP:0100614) | 1.88766971 |
| 81 | Genetic anticipation (HP:0003743) | 1.88686897 |
| 82 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87170319 |
| 83 | CNS demyelination (HP:0007305) | 1.85389722 |
| 84 | Progressive inability to walk (HP:0002505) | 1.82996411 |
| 85 | Eosinophilia (HP:0001880) | 1.82654103 |
| 86 | Ketoacidosis (HP:0001993) | 1.82475384 |
| 87 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.82396033 |
| 88 | Spontaneous hematomas (HP:0007420) | 1.81702581 |
| 89 | Renal cortical cysts (HP:0000803) | 1.81469940 |
| 90 | Abnormality of macular pigmentation (HP:0008002) | 1.79755299 |
| 91 | Palpebral edema (HP:0100540) | 1.79511821 |
| 92 | Episodic fever (HP:0001954) | 1.79464862 |
| 93 | Chronic obstructive pulmonary disease (HP:0006510) | 1.74900766 |
| 94 | Obstructive lung disease (HP:0006536) | 1.74900766 |
| 95 | Respiratory failure (HP:0002878) | 1.73251903 |
| 96 | Constricted visual fields (HP:0001133) | 1.73207261 |
| 97 | Abnormality of the intervertebral disk (HP:0005108) | 1.71991547 |
| 98 | Respiratory difficulties (HP:0002880) | 1.70568303 |
| 99 | Abnormality of the renal medulla (HP:0100957) | 1.69308072 |
| 100 | Microcytic anemia (HP:0001935) | 1.69220445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 5.27598781 |
| 2 | TXK | 4.46447978 |
| 3 | TESK2 | 3.54112277 |
| 4 | ADRBK2 | 3.18042414 |
| 5 | ZAK | 3.12612637 |
| 6 | MAP3K12 | 2.89065659 |
| 7 | FRK | 2.69503547 |
| 8 | MAP2K7 | 2.65480142 |
| 9 | BCKDK | 2.64973837 |
| 10 | MAP4K2 | 2.20677218 |
| 11 | MAP4K1 | 2.06820287 |
| 12 | TRIM28 | 2.03729112 |
| 13 | MAP3K4 | 1.98903838 |
| 14 | WNK3 | 1.91610522 |
| 15 | GRK1 | 1.89705193 |
| 16 | LIMK1 | 1.83386167 |
| 17 | TESK1 | 1.67024824 |
| 18 | PIK3CA | 1.40412965 |
| 19 | SYK | 1.33763033 |
| 20 | VRK2 | 1.31646978 |
| 21 | JAK3 | 1.31102213 |
| 22 | ERBB3 | 1.30582608 |
| 23 | MAP3K6 | 1.25543649 |
| 24 | GRK6 | 1.20222655 |
| 25 | TLK1 | 1.20104611 |
| 26 | ITK | 1.18353334 |
| 27 | GRK7 | 1.17003790 |
| 28 | PRKCQ | 1.12265616 |
| 29 | IKBKE | 1.11513211 |
| 30 | KIT | 1.10869838 |
| 31 | CAMKK2 | 1.07623952 |
| 32 | VRK1 | 1.06796689 |
| 33 | MAP3K11 | 1.02641042 |
| 34 | PINK1 | 1.02533299 |
| 35 | TAOK3 | 1.01144687 |
| 36 | LRRK2 | 0.99578920 |
| 37 | LYN | 0.98085268 |
| 38 | MAPK13 | 0.97983569 |
| 39 | MYLK | 0.97910857 |
| 40 | MAPKAPK3 | 0.96066911 |
| 41 | STK16 | 0.96045132 |
| 42 | LCK | 0.95801043 |
| 43 | TNK2 | 0.91557541 |
| 44 | CSF1R | 0.91547088 |
| 45 | TIE1 | 0.91174993 |
| 46 | PIM1 | 0.90236318 |
| 47 | MAP3K5 | 0.88403845 |
| 48 | TEC | 0.87881566 |
| 49 | BUB1 | 0.81835750 |
| 50 | MAP2K6 | 0.79510730 |
| 51 | FES | 0.79161146 |
| 52 | PTK2B | 0.77709805 |
| 53 | FLT3 | 0.77388403 |
| 54 | MST4 | 0.76410182 |
| 55 | ADRBK1 | 0.75807207 |
| 56 | BTK | 0.74737268 |
| 57 | NTRK2 | 0.73509395 |
| 58 | ZAP70 | 0.72822381 |
| 59 | WNK4 | 0.71091118 |
| 60 | PIM2 | 0.68579174 |
| 61 | CSK | 0.67918837 |
| 62 | DYRK1B | 0.66141812 |
| 63 | INSRR | 0.64840766 |
| 64 | RIPK4 | 0.64002795 |
| 65 | PKN1 | 0.62148813 |
| 66 | DAPK1 | 0.61937227 |
| 67 | IRAK4 | 0.61675338 |
| 68 | RPS6KA5 | 0.61153165 |
| 69 | DAPK2 | 0.60285284 |
| 70 | TYRO3 | 0.58808412 |
| 71 | IKBKB | 0.57954729 |
| 72 | DYRK2 | 0.57046509 |
| 73 | NUAK1 | 0.55674141 |
| 74 | UHMK1 | 0.55670088 |
| 75 | ROCK1 | 0.54792682 |
| 76 | AKT3 | 0.54727988 |
| 77 | MAP2K4 | 0.51367806 |
| 78 | MAPKAPK5 | 0.48417810 |
| 79 | OBSCN | 0.48232372 |
| 80 | IGF1R | 0.47586882 |
| 81 | CDK3 | 0.47228991 |
| 82 | BLK | 0.45691666 |
| 83 | YES1 | 0.44552513 |
| 84 | GRK5 | 0.44275701 |
| 85 | CAMK2A | 0.44244062 |
| 86 | PRKACA | 0.43358648 |
| 87 | FYN | 0.41222594 |
| 88 | JAK2 | 0.39944567 |
| 89 | PIK3CG | 0.39294806 |
| 90 | PRKCA | 0.36271757 |
| 91 | PLK2 | 0.33989233 |
| 92 | CAMK4 | 0.29308657 |
| 93 | ABL1 | 0.28365172 |
| 94 | EGFR | 0.28169869 |
| 95 | BMPR2 | 0.27916059 |
| 96 | PRKCE | 0.27564088 |
| 97 | MAPK3 | 0.27563030 |
| 98 | CSNK2A1 | 0.27389114 |
| 99 | CASK | 0.27295605 |
| 100 | CAMK1 | 0.26446231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.77662361 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.69254253 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.33347574 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.09823037 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.95023394 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.93311756 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.56137226 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.53104593 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.37375938 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.25579931 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.16390981 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06517195 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.05832838 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.05190851 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96799240 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.89347668 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.85626463 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.77307593 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.62249413 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.58987230 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56796130 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.51279112 |
| 23 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.49936988 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48441805 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.44990758 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.43884329 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.39202640 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.37447840 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32617834 |
| 30 | RNA polymerase_Homo sapiens_hsa03020 | 1.32386241 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.28306597 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25052132 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23946708 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.23570661 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21075615 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.16043695 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14751319 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13548980 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10728730 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09387869 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.07539887 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01520768 |
| 43 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.97119612 |
| 44 | Nicotine addiction_Homo sapiens_hsa05033 | 0.95026173 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92633503 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.91237064 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88189824 |
| 48 | Measles_Homo sapiens_hsa05162 | 0.85991301 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84909483 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84507919 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81928781 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79729635 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79602106 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78876448 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75137309 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74606436 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70904224 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.70848481 |
| 59 | Olfactory transduction_Homo sapiens_hsa04740 | 0.70295331 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68047523 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.66826200 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64479586 |
| 63 | Morphine addiction_Homo sapiens_hsa05032 | 0.63574437 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.63145701 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62301032 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61330579 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60141905 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55489729 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55162857 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54870221 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52680334 |
| 72 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51683038 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49583589 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.47724797 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.47540642 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47444680 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45761012 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.45183185 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43129776 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42399443 |
| 81 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41937313 |
| 82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41418307 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40676149 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36650650 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36407178 |
| 86 | Homologous recombination_Homo sapiens_hsa03440 | 0.35815189 |
| 87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.33733816 |
| 88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31874354 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31509055 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31018666 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.30619080 |
| 92 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.30466203 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29851709 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.29564528 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.28350001 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28053637 |
| 97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.27125463 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26191571 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.26080305 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24247743 |

